Fortive Corporation
NYQ: FTVLive Quote
📈 ZcoreAI Score
Our AI model analyzes Fortive Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get FTV Z-Score →About Fortive Corporation
Technology
Scientific & Technical Instruments
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
📊 Fundamental Analysis
Fortive Corporation demonstrates a profit margin of 13.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 4.6% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 6.4%, which suggests room for improvement in capital utilization.
At a current price of $58.36, FTV currently sits at the 75th percentile of its 52-week range (Range: $46.34 - $62.42).
💰 Valuation Insight
FTV is valued broadly in line with the sector at a PE of 36.70. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$18.54B
Trailing P/E
36.70
Forward P/E
18.27
Beta (5Y)
1.00
52W High
$62.42
52W Low
$46.34
Avg Volume
3.80M
Day High
Day Low